Atlas Trials

The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery

Clinical trial NCT07442539 · RECRUITING

Trial details

NCT number
NCT07442539
Sponsor
Beijing Tiantan Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hemorrhoid SurgeryLiposome BupivacainePain ManagementLocal Infiltration
Start date
2026-03-02
Primary completion
2027-03-30
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.